Julia Stingl

Professor

RWTH Aachen

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

80%

Pharmacotherapy

100%

Pharmacometrics

40%

Drug Safety

40%

Medical Science

40%

Pharmacogenomic

40%

Emergency Medicine

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset

Article Link

Year:

2024

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Article Link

Year:

2023

Prevalence and determinants of over- and undertreatment among users of antihypertensive drugs in the general population: the Rhineland Study

Article Link

Year:

2023

The gradient model of brain organization in decisions involving "empathy for pain"

Article Link

Year:

2023

Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study

Article Link

Year:

2023

Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations

Article Link

Year:

2023

Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports

Article Link

Year:

2023

Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera

Article Link

Year:

2022

Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations.

Article Link

Year:

2022

Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes

Article Link

Year:

2022

Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.

Article Link

Year:

2022

Optimal@NRW: optimized acute care of nursing home residents using an intersectoral telemedical cooperation network - study protocol for a stepped-wedge trial.

Article Link

Year:

2022

Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions.

Article Link

Year:

2022

Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant - implications for precision dosing in a global perspective.

Article Link

Year:

2022

Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes.

Article Link

Year:

2022

Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.

Article Link

Year:

2022

Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial.

Article Link

Year:

2022

Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes

Article Link

Year:

2022

Collaborators8

Barbara Schnierle

Paul-Ehrlich-Institut

GERMANY

Marie-Luise Herrlein

Paul-Ehrlich-Institut

GERMANY

Albrecht Eisert

Assistent Professor

University Hospital

GERMANY

Roberto Viviani

University of Innsbruck

AUSTRIA

Panagiotis Ferentinos

Associate Professor of Psychiatry

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE

Corinna Ernst

University of Cologne

GERMANY

Emilio Guirao-Arrabal

SPAIN

Kathrin Blagec

Medical University of Vienna

AUSTRIA

How do I reach out?

Meet Kite AI